Literature DB >> 2753333

Evaluation of computed tomography in the assessment of liver iron overload. A study of 46 cases of idiopathic hemochromatosis.

D Guyader1, Y Gandon, Y Deugnier, H Jouanolle, O Loreal, M Simon, M Bourel, M Carsin, P Brissot.   

Abstract

The aim of the present study was to evaluate the effectiveness of single-energy computed tomography in determining iron overload in idiopathic hemochromatosis, with special reference to slightly overloaded cases. Liver attenuation was determined in 100 patients (46 cases of idiopathic hemochromatosis, 32 cases of chronic liver disease, and 22 normal controls). The iron load was determined for the first two groups by biochemical determination of liver iron concentration (performed in all but 12 subjects in the chronic liver disease group) and hepatic histologic grading. The main results for liver attenuation (upper normal limit, 72 Hounsfield units) showed that despite a high specificity (0.96), this parameter was of low sensitivity (0.63). Although mean liver attenuation in idiopathic hemochromatosis (77 +/- 14) was significantly higher than in chronic liver diseases (53 +/- 17; p less than 10(-4) and normal controls (66 +/- 3; p less than 10(-3], and despite an overall good correlation between liver attenuation and liver iron concentration (r = 0.72; p less than 10(-3], liver attenuation was unable to detect moderate iron overload. Fourteen of 18 patients with a liver iron concentration of less than 150 mumol/g dry liver wt had liver attenuation values of less than 72. Moreover, 3 of 18 subjects with a liver iron concentration of greater than 150 had a liver attenuation of less than 72. Of these 17 false-negatives, only 7 could be attributed to associated steatosis. On the whole, single-energy computed tomography, when used on a routine basis for diagnosing iron overload, is of limited clinical value in idiopathic hemochromatosis due to its poor sensitivity. Hepatic histologic examination together with biochemical determination remains the most accurate means to assess liver iron.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2753333     DOI: 10.1016/0016-5085(89)90646-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

Review 1.  Magnetic resonance imaging quantification of liver iron.

Authors:  Claude B Sirlin; Scott B Reeder
Journal:  Magn Reson Imaging Clin N Am       Date:  2010-08       Impact factor: 2.266

2.  Different forms of iron accumulation in the liver on MRI.

Authors:  İlkay S İdilman; Deniz Akata; Mustafa Nasuh Özmen; Muşturay Karçaaltıncaba
Journal:  Diagn Interv Radiol       Date:  2016 Jan-Feb       Impact factor: 2.630

3.  Computed tomography in nonalcoholic fatty liver disease: a useful tool for hepatosteatosis assessment?

Authors:  Deniz Güney Duman; Cigdem Celikel; Davut Tüney; Nese Imeryüz; Erol Avsar; Nurdan Tözün
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

Review 4.  Assessing the Non-tumorous Liver: Implications for Patient Management and Surgical Therapy.

Authors:  Pallavi Pandey; Ankur Pandey; Mary Dillhoff; Carl Schmidt; Ihab R Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-09-18       Impact factor: 3.452

5.  Iron overload in urban Africans in the 1990s.

Authors:  I T Gangaidzo; V M Moyo; T Saungweme; H Khumalo; R M Charakupa; Z A Gomo; M Loyevsky; R Stearman; T La Vaute; E G Enquist; T A Rouault; V R Gordeuk
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

Review 6.  Iron overload cardiomyopathy: better understanding of an increasing disorder.

Authors:  Pradeep Gujja; Douglas R Rosing; Dorothy J Tripodi; Yukitaka Shizukuda
Journal:  J Am Coll Cardiol       Date:  2010-09-21       Impact factor: 24.094

7.  Influence of iron chelation on R1 and R2 calibration curves in gerbil liver and heart.

Authors:  John C Wood; Michelle Aguilar; Maya Otto-Duessel; Hanspeter Nick; Marvin D Nelson; Rex Moats
Journal:  Magn Reson Med       Date:  2008-07       Impact factor: 4.668

Review 8.  Iron overload cardiomyopathies: new insights into an old disease.

Authors:  P Liu; N Olivieri
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

9.  Bone marrow changes in beta-thalassemia major: quantitative MR imaging findings and correlation with iron stores.

Authors:  Eleni E Drakonaki; Thomas G Maris; Alex Papadakis; Apostolos H Karantanas
Journal:  Eur Radiol       Date:  2006-12-16       Impact factor: 7.034

10.  Hypoparathyroidism and subclinical hypothyroidism with secondary hemochromatosis.

Authors:  Hyung Ki Jeong; Joon Hwan An; Hyoung Sang Kim; Eun Ae Cho; Min Gui Han; Jung Sik Moon; Hee Kyung Kim; Ho-Cheol Kang
Journal:  Endocrinol Metab (Seoul)       Date:  2014-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.